Are we already able to assess our patients accurately for MI risk factors or is there another test that could provide more accuracy? Our guest today, Dr. Jeffrey Gulcher, chief scientific officer and co-founder of deCode Genetics tells host, Dr. Larry Kaskel about deCode MI. Learn how to use and interpret the results of the new decode MI test. What can you learn that you don't already know?
deCode MI: Another Tool to Assess Patient's MI Risk
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Are we already able to assess our patients accurately for MI risk factors or is there another test that could provide more accuracy? Our guest today, Dr. Jeffrey Gulcher, chief scientific officer and co-founder of deCode Genetics tells host, Dr. Larry Kaskel about deCode MI. Learn how to use and interpret the results of the new decode MI test. What can you learn that you don't already know?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
CME/CE
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
0.50 credits
<p>IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
<p><span data-contrast="auto" xml:lang="EN-US">Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow</span><span data-ccp-props='{"201341983":0,"335559739":0,"335559740":240}'> </span></p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
CME/CE
Collaborative Insights to Solve the Puzzle of Bladder Cancer
1.00 credits
<p><span data-contrast="auto" style="list-style-type: disc;" xml:lang="EN-US">Collaborative Insights to Solve the Puzzle of Bladder Cancer</span></p>
MinuteCE®
Understanding hypertrophic cardiomyopathy and recent guidelines
0.52 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">Understanding hypertrophic cardiomyopathy and recent guidelines</span></p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?